Feedback

Overexpression of Cx43: Is It an Effective Approach for the Treatment of Cardiovascular Diseases?

Affiliation
Institute of Physiology, Justus-Liebig University, 35392 Giessen, Germany
Boengler, Kerstin;
ORCID
0009-0000-3263-7944
Affiliation
Department of Clinical and Biological Sciences, University of Torino, 10125 Torino, Italy
Mantuano, Beatrice;
ORCID
0000-0002-2590-6066
Affiliation
Department of Physiology, Biophysics and Systems Biology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3190601, Israel
Toledano, Shira;
Affiliation
Department of Physiology, Biophysics and Systems Biology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3190601, Israel
Binah, Ofer;
ORCID
0000-0003-3017-0476
Affiliation
Institute of Physiology, Justus-Liebig University, 35392 Giessen, Germany
Schulz, Rainer

In the heart, Connexin 43 (Cx43) is involved in intercellular communication through gap junctions and exosomes. In addition, Cx43-formed hemichannels at the plasma membrane are important for ion homeostasis and cellular volume regulation. Through its localization within nuclei and mitochondria, Cx43 influences the function of the respective organelles. Several cardiovascular diseases such as heart failure, ischemia/reperfusion injury, hypertrophic cardiomyopathy and arrhythmias are characterized by Cx43 downregulation and a dysregulated Cx43 function. Accordingly, a putative therapeutic approach of these diseases would include the induction of Cx43 expression in the damaged heart, albeit such induction may have both beneficial and detrimental effects. In this review we discuss the consequences of increasing cardiac Cx43 expression, and discuss this manipulation as a strategy for the treatment of cardiovascular diseases.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: © 2025 by the authors.

Use and reproduction: